ConvergeHEALTH Patient Connect™ will serve as the foundation of Amgen’s patient services strategy
Deloitte today announced the debut of a global initiative with Amgen to launch an integrated patient services platform powered by ConvergeHEALTH Patient Connect™. The cloud-based, scalable platform will help Amgen bring disparate patient services together and provide a connected engagement experience for its patients.
“In a complicated, and increasingly difficult-to-navigate health care environment, patient-centric services are critical to ensure patients that need Amgen therapeutics are supported in their individual journeys,” said Claes Hornstrand, vice president, U.S. value & access, Amgen. “Amgen has selected ConvergeHEALTH Patient Connect to help us meet the complex and varied needs of our patients. This is core to Amgen’s unwavering mission to serve patients.”
ConvergeHEALTH Patient Connect enables customer-centered patient engagement by improving patient experience, accelerating access to therapy, and increasing insights into patient needs and preferences. The capabilities and flexible configurability of ConvergeHEALTH Patient Connect will facilitate consolidation of multiple global systems into one platform to enhance Amgen’s ability to deliver consistent, high-touch customer experiences across channels. As Amgen works to meet the needs of patients with complex disease states, ConvergeHEALTH Patient Connect will help deliver coordinated care across its global enterprise.
“As we continue to evolve Patient Connect to meet the many diverse needs of our clients, we believe Amgen has chosen the leading packaged software solution to provide these services across their global enterprise,” said Chris Zant, principal, Deloitte Consulting LLP, and co-lead for life sciences with Deloitte Digital.